Literature DB >> 30233960

Treatment of Hip Flexion Contractures with Psoas Recession Through the Middle Window of the Ilioinguinal Approach.

Daniel J Gittings1, Jonathan R Dattilo1, George Fryhofer1, Derek J Donegan1, Keith Baldwin1.   

Abstract

INTRODUCTION: The ilioinguinal approach for psoas recession over the pelvic brim allows for direct visualization and protection of the femoral nerve while preserving hip flexion strength. STEP 1 PATIENT POSITIONING PREOPERATIVE ASSESSMENT AND DRAPING: With the patient supine and anesthetized, perform the Thomas test, administer antibiotics, and drape to provide access to the inferior aspect of the abdomen, ilioinguinal region, and lower limb. STEP 2 SUPERFICIAL DISSECTION: Mark the osseous landmarks, draw a line connecting the anterior superior iliac spine to the pubic tubercle, and make a bikini incision along this line. STEP 3 DEEP DISSECTION: Incise the external oblique aponeurosis and internal oblique and transverse abdominal muscles from the anterior superior iliac spine to the pubic tubercle, leaving a 2-mm cuff of tissue. STEP 4 PSOAS RECESSION: After protecting the femoral nerve, confirm the identity of the psoas with 3 tests and transect it with cautery. STEP 5 POSTOPERATIVE MANAGEMENT: Physical therapy is initiated immediately and includes static and dynamic hip extension exercises that stretch the anterior hips structures.
RESULTS: Hip flexion contracture is a debilitating condition that affects many patients with spastic paresis or prior hip trauma.

Entities:  

Year:  2017        PMID: 30233960      PMCID: PMC6132711          DOI: 10.2106/JBJS.ST.16.00075

Source DB:  PubMed          Journal:  JBJS Essent Surg Tech        ISSN: 2160-2204


  9 in total

1.  Force- and moment-generating capacity of lower-extremity muscles before and after tendon lengthening.

Authors:  S L Delp; F E Zajac
Journal:  Clin Orthop Relat Res       Date:  1992-11       Impact factor: 4.176

2.  Psoas over the brim lengthenings. Anatomic investigation and surgical technique.

Authors:  D L Skaggs; C K Kaminsky; E Eskander-Rickards; R A Reynolds; V T Tolo; G S Bassett
Journal:  Clin Orthop Relat Res       Date:  1997-06       Impact factor: 4.176

3.  Psoas release at the pelvic brim in ambulatory patients with cerebral palsy: operative technique and functional outcome.

Authors:  D H Sutherland; J L Zilberfarb; K R Kaufman; M P Wyatt; H G Chambers
Journal:  J Pediatr Orthop       Date:  1997 Sep-Oct       Impact factor: 2.324

4.  Postural and gait abnormalities caused by hip-flexion deformity in spastic cerebral palsy. Treatment by iliopsoas recession.

Authors:  E E Bleck
Journal:  J Bone Joint Surg Am       Date:  1971-12       Impact factor: 5.284

5.  Evaluation of conventional selection criteria for psoas lengthening for individuals with cerebral palsy: a retrospective, case-controlled study.

Authors:  Walter H Truong; Adam Rozumalski; Tom F Novacheck; Cammie Beattie; Michael H Schwartz
Journal:  J Pediatr Orthop       Date:  2011 Jul-Aug       Impact factor: 2.324

6.  Intramuscular psoas lengthening improves dynamic hip function in children with cerebral palsy.

Authors:  Tom F Novacheck; Joyce P Trost; Michael H Schwartz
Journal:  J Pediatr Orthop       Date:  2002 Mar-Apr       Impact factor: 2.324

7.  The surgical treatment of internal snapping hip.

Authors:  Gary S Gruen; Thomas N Scioscia; Jason E Lowenstein
Journal:  Am J Sports Med       Date:  2002 Jul-Aug       Impact factor: 6.202

8.  Effects of intramuscular psoas lengthening on pelvic and hip motion in patients with spastic diparetic cerebral palsy.

Authors:  Mauro C Morais Filho; Wagner de Godoy; Carlos A Santos
Journal:  J Pediatr Orthop       Date:  2006 Mar-Apr       Impact factor: 2.324

9.  Iliopsoas tenotomy at the lesser trochanter versus at the pelvic brim in ambulatory children with cerebral palsy.

Authors:  Gad M Bialik; Rosemary Pierce; Robin Dorociak; Tack Shin Lee; Michael D Aiona; Michael D Sussman
Journal:  J Pediatr Orthop       Date:  2009 Apr-May       Impact factor: 2.324

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.